Dr. Blankson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10755 Falls Road
Pavilion I
Lutherville, MD 21093Phone+1 410-955-1725- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2002
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
- Weill Cornell MedicineClass of 1995
Certifications & Licensure
- MD State Medical License 1998 - 2024
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4T cell clonotypes.Joel Sop, Caroline C Traut, Arbor G Dykema, Joanne H Hunt, Tyler P Beckey, Christie R Basseth, Annukka A R Antar, Oliver Laeyendecker, Kellie N Smith, Joel N Blankson> ;Cell Reports. Medicine. 2024 Mar 19
- Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.Andrew H Karaba, William R Morgenlander, Trevor S Johnston, Camille Hage, Andrew Pekosz, Christine M Durand, Dorry L Segev, Mark A Robien, Peter S Heeger, Christian P ...> ;The Journal of Infectious Diseases. 2023 Nov 29
- Immune Responses in Controllers of HIV Infection.Abena K Kwaa, Joel N Blankson> ;Annual Review of Immunology. 2023 Oct 12
- Join now to see all
Journal Articles
- Interferon-Α Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T CellsJoel Blankson, MD, mBio
- CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in HumansJustin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine
- Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1Peter A Anton, Jennifer A Fulcher, Otto O Yang, Joel N Blankson, The Journal of Infectious Diseases
Press Mentions
- Breakthrough COVID Infections More Likely in People Living with HIVJune 9th, 2022
- Antibodies from Covid Vaccines May Be Weaker Against Omicron, Study FindsApril 27th, 2022
- Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against OmicronApril 26th, 2022
- Join now to see all
Grant Support
- CD8+ T Cell Mediated Inhibition Of HIV-1 Replication In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2009–2012
- Analysis Of HIV-1 In Mucosal Tissue In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2011
- Characterization Of HIV Excape Mutants And T Cell Responses In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2007
- Latent Virus And HIV-1 Specific Immunity In LtnpsNational Institute Of Allergy And Infectious Diseases2002–2006
- Latency &Cell Distribution Of Virus In HIV1 InfectionNational Institute Of Allergy And Infectious Diseases1998–2000
- Minority Predoctoral Fellowship ProgramNational Institute Of General Medical Sciences1991–1992
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/joel-blankson
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: